Arax Advisory Partners’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $46.6K | Buy |
624
+609
| +4,060% | +$45.4K | ﹤0.01% | 1273 |
|
|
2025
Q1 | $954 | Buy |
15
+6
| +67% | +$382 | ﹤0.01% | 2315 |
|
|
2024
Q4 | $703 | Sell |
9
-30
| -77% | -$2.34K | ﹤0.01% | 2248 |
|
|
2024
Q3 | $3.14K | Hold |
39
| – | – | ﹤0.01% | 1905 |
|
|
2024
Q2 | $3.23K | Buy |
+39
| New | +$3.23K | ﹤0.01% | 1793 |
|
|
2023
Q4 | – | Sell |
-7
| Closed | -$628 | – | 1377 |
|
|
2023
Q3 | $628 | Sell |
7
-13
| -65% | -$1.17K | ﹤0.01% | 1214 |
|
|
2023
Q2 | $1.7K | Sell |
20
-18
| -47% | -$1.53K | ﹤0.01% | 1028 |
|
|
2023
Q1 | $3.15K | Buy |
38
+25
| +192% | +$2.07K | ﹤0.01% | 942 |
|
|
2022
Q4 | $1.02K | Hold |
13
| – | – | ﹤0.01% | 1067 |
|
|
2022
Q3 | $1K | Buy |
+13
| New | +$1K | ﹤0.01% | 1081 |
|